| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,554 |
18,974 |
$1.51M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,880 |
16,165 |
$943K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,675 |
3,603 |
$262K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
715 |
696 |
$79K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,691 |
1,667 |
$67K |
| 87428 |
|
1,214 |
1,206 |
$63K |
| 99215 |
Prolong outpt/office vis |
307 |
287 |
$32K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
524 |
497 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,364 |
998 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
884 |
877 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
1,846 |
1,734 |
$6K |
| 81003 |
|
2,085 |
2,025 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
590 |
559 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
248 |
123 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
146 |
141 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
605 |
524 |
$952.33 |
| 71046 |
Radiologic examination, chest; 2 views |
29 |
28 |
$423.42 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
13 |
$420.29 |
| 90674 |
|
12 |
12 |
$226.64 |
| 99307 |
|
14 |
12 |
$189.02 |